Medicare Coverage Begins for Diapulse Wound Treatment.GREAT NECK, N.Y. -- Diapulse Corporation of America (OTC- DIAC DIAC Department of Immigration and Citizenship (Australia) DIAC Defense Intelligence Analysis Center DIAC Dedicated Inquiry Access Code (Bluetooth) DIAC Defense Industry Advisory Council ) announced today that based on a recent decision the Centers for Medicare and Medicaid Services The Centers for Medicare and Medicaid Services (CMS), previously known as the Health Care Financing Administration (HCFA), is a federal agency within the United States Department of Health and Human Services (DHHS) that administers the Medicare program and (CMS (1) See content management system and color management system. (2) (Conversational Monitor System) Software that provides interactive communications for IBM's VM operating system. ) will begin Medicare coverage implementation today for the Diapulse Wound Treatment System. David M. Ross, Vice President of Diapulse Corporation of America, said, "Coverage will allow hospitals, nursing homes, physicians and rehabilitation clinics to obtain reimbursement for patients treated with Diapulse Therapy for chronic wounds." The Heathcare Common Procedure Coding System known as HCPCS HCPCS Healthcare Common Procedure Coding System , established an applicable new code that will cover Diapulse treatment. Under Nationally Covered Indications, the use of Diapulse Therapy will be covered for payment as an adjunct for chronic Stage III or Stage IV pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis venous stasis Medtalk The pooling of venous blood in a particular region which, in the legs results in edema, hyperpigmentation and possibly ulceration ulcers. With Medicare coverage, the addition of Diapulse medical technology will allow institutions such as hospitals and nursing homes to provide improved quality of patient care as well as a platform for cost savings. "There are many people that know of or have a family member, relative or friend, especially elderly, in a nursing home who has a chronic wound that could benefit from our technology," Mr. Ross said. A significant advantage of Diapulse, non-thermal pulsed electromagnetic energy, is that it can treat wounds safely and effectively directly through bandages, clothing and surgical dressings. Diapulse Corporation of America, a publicly traded Company publicly traded company A company whose shares of common stock are held by the public and are available for purchase by investors. The shares of publicly traded firms are bought and sold on the organized exchanges or in the over-the-counter market. listed Over-The-Counter Symbol DIAC, is the pioneer and leader in the biophysical therapeutic effects of non-thermal pulsed electromagnetic energy in medicine. The Company manufacturers, researches and develops the proprietary Diapulse Technology, indicated for the adjunctive use in the palliative treatment of postoperative edema edema (ĭdē`mə), abnormal accumulation of fluid in the body tissues or in the body cavities causing swelling or distention of the affected parts. and pain in superficial soft tissues. Diapulse is a registered trademark of Diapulse Corporation of America. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion